PointCross Life Sciences Blog

PointCross announces SEND-ASSURE for Data Consistency in Submissions to the FDA

Posted by PointCross Life Sciences on Jan 19, 2017 2:36:20 PM

SEND-ASSURE is an audit solution to reduce risks in Regulatory e-Data Submissions

Read More

PointCross announces SEND-ASSURE for Data Consistency in Submissions to the FDA

Posted by PointCross Life Sciences on Jan 19, 2017 2:35:54 PM

SEND-ASSURE is an audit solution to reduce risks in Regulatory e-Data Submissions

Read More

NIMS Version 2.5 for SEND released to the FDA, Now Available for Industry

Posted by PointCross Life Sciences on Jan 19, 2017 2:35:24 PM

NIMS enables faster, deeper and more insightful regulatory review of nonclinical study data for safety signal detection and analysis

Read More

PointCross announces SaaS offerings on the cloud to span the entire lifecycle of eData submissions to FDA

Posted by PointCross Life Sciences on Jan 19, 2017 2:34:57 PM

Nonclinical Study Data Specification (NSDS) for definition of a study before it begins, and ToxVision-as-a-software-Service to review studies after they are completed using the same visualization and analysis tools as in FDA’s NIMS are now available as a software subscription. 

Read More

PointCross Life Sciences and CAC EXICARE forge strategic implementation plan

Posted by PointCross Life Sciences on Jan 19, 2017 2:34:05 PM
Read More

PointCross Life Sciences and Smithers Avanza forge strategic partnership for SEND solutions

Posted by PointCross Life Sciences on Jan 19, 2017 2:33:26 PM

For biopharma companies, this collaboration will streamline the flow of high quality CDISC SEND standardized data for regulatory submissions required by the FDA and to serve sponsor R&D needs

Read More

PointCross Life Sciences’ SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDA’s Upcoming e-Data Submission Mandate

Posted by PointCross Life Sciences on Jan 19, 2017 2:31:44 PM

PointCross Life Sciences’ SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDA’s Upcoming e-Data Submission Mandate

FOSTER CITY, CA, March 11, 2013 PRNewswire

Read More